Europe Automated External Defibrillator (AED) Market, By Product Type (Semi-Automated External Defibrillators, Fully-Automated External Defibrillators), End-User (Pre-hospitals, Public Access Facilities, Hospitals, Alternate Care, Home) – Industry Trends and Forecast to 2030.
Europe Automated External Defibrillator (AED) Market Analysis and Size
The Europe automated external defibrillator (AED) market has witnessed substantial growth in recent years. Factors such as increasing awareness about cardiac health, rising incidences of cardiovascular diseases, and proactive government initiatives have contributed to the expansion of this market. Here is an in-depth analysis of drivers, restraints, opportunities, and challenges influencing this market.
Data Bridge Market Research analyses that the Europe automated external defibrillator (AED) market was valued at USD 321.34 million in 2022 and is expected to reach the value of USD 891.34 million by the year 2030, at a CAGR of 9.49% during the forecast period 2023-2030. “Resting ECG Systems” dominates the product type segment of the Europe automated external defibrillator (AED) market owing to the growing demand for advancement in AED technology. In addition to the insights on market scenarios such as market value, growth rate, segmentation, geographical coverage, and major players, the market reports curated by the Data Bridge Market Research also include depth expert analysis, patient epidemiology, pipeline analysis, pricing analysis, and regulatory framework.
Europe Automated External Defibrillator (AED) Market Scope and Segmentation
Report Metric |
Details |
Forecast Period |
2023 to 2030 |
Base Year |
2022 |
Historic Years |
2021 (Customizable to 2015-2020) |
Quantitative Units |
Revenue in USD Million, Volumes in Units, Pricing in USD |
Segments Covered |
Product Type (Semi-Automated External Defibrillators, Fully-Automated External Defibrillators), End-User (Pre-hospitals, Public Access Facilities, Hospitals, Alternate Care, Home) |
Countries Covered |
U.K., Germany, France, Italy, Spain, Netherlands, Switzerland, Belgium, Turkey, Russia and Rest of Europe |
Market Players Covered |
Philips Healthcare (Netherlands), GE Healthcare (U.S.), Siemens Healthineers (Germany), Hillrom Holdings, Inc. (U.S.), Schiller AG (Switzerland), Fukuda Denshi Co., Ltd. (Japan), Mindray Medical International Limited (China), Nihon Kohden Corporation (Japan), Mortara Instrument, Inc. (U.S.), BPL Medical Technologies (India), Medtronic plc (U.S.) |
Market Opportunities |
|
Market Definition
An Automated External Defibrillator (AED) is a portable electronic device designed to diagnose and treat life-threatening cardiac arrhythmias through the application of electrical therapy. These life-saving devices are used in emergency situations to deliver a shock to the heart to restore a normal rhythm during sudden cardiac arrest (SCA).
Europe Automated External Defibrillator (AED) Market Dynamics
Drivers
- Rising Incidences of Sudden Cardiac Arrest (SCA)
SCA remains a leading cause of mortality in Europe. The increasing prevalence of risk factors like obesity and sedentary lifestyles contributes to a higher likelihood of SCA. Consequently, there is a growing need for AEDs to enhance the chances of survival. This in turn has carved the way for the growth of the market.
- Growing Aging Population
The aging population is more prone to cardiac conditions, and as the Europe population continues to age, the demand for cardiac diagnostics, including ECG, rises accordingly. The elderly population requires regular cardiac monitoring and screening for age-related cardiovascular diseases. This demographic trend is expected to boost market growth.
- Technological Advancements
Advancements in ECG device technology, such as wireless and portable devices, improved connectivity, enhanced data analysis algorithms, and user-friendly interfaces, have made ECG testing more accessible and convenient. These technological innovations are further creating lucrative market growth.
Opportunity
- Government Initiatives
The government initiatives, schemes, or funding that support and promotes the innovation and development of the diagnostic market provide growth opportunities for the market players in the forecast period of 2023 to 2030. Additionally, rising cardiovascular disease penetration rate, increasing adoption of digital health solution, rise in the personalized and precise diagnostics Europely and increasing per capita expenditure on health care will further expand the market's growth rate in the future.
Restraints/ Challenges
- High Initial Costs
AEDs can be expensive to purchase and maintain. The initial investment required for procurement, training, and maintenance can be a barrier, particularly for smaller organizations or resource-constrained regions are expected to obstruct market growth.
- High Cost Associated with R&D
On the other hand, high cost associated with the research and development proficiencies, limited infrastructural facilities, high cost associated with the chemical analyser in the backward economies are expected to obstruct market growth. Also, lack of favorable reimbursement scenario and technology penetration in the developing economies, heavy custom duty imposed on the medical devices, and lack of suitable infrastructure in low- and middle-income countries are projected to challenge the market in the forecast period of 2023-2030.
This Europe automated external defibrillator (AED) market report provides details of new recent developments, trade regulations, import-export analysis, production analysis, value chain optimization, market share, impact of domestic and localized market players, analyses opportunities in terms of emerging revenue pockets, changes in market regulations, strategic market growth analysis, market size, category market growths, application niches and dominance, product approvals, product launches, geographic expansions, technological innovations in the market. To gain more info on the Europe automated external defibrillator (AED) market contact Data Bridge Market Research for an Analyst Brief, our team will help you take an informed market decision to achieve market growth.
Recent Developments
- In August 2021, Kestra Medical Technologies, Inc. announced that the company received the premarket approval from the U.S. Food and Drug Administration (FDA) for the ASSURE Wearable Cardioverter Defibrillator (WCD) system
- In June 2021, Rapid Response Revival (RRR) earned CE mark certification in Europe for their personal automated external defibrillator (AED), CellAED
Europe Automated External Defibrillator (AED) Market Scope
The Europe automated external defibrillator (AED) market is segmented on the basis of product type, and end-user. The growth amongst these segments will help you analyse meagre growth segments in the industries and provide the users with a valuable market overview and market insights to help them make strategic decisions for identifying core market applications.
Product Type
- Semi-Automated External Defibrillators
- Fully-Automated External Defibrillators
End-User
- Pre-Hospitals,
- Public Access Facilities
- Hospitals
- Alternate Care
- Home
Europe Automated External Defibrillator (AED) Market Regional Analysis/Insights
The Europe automated external defibrillator (AED) market is analysed and market size insights and trends are provided by country, product type and end-user as referenced above.
The countries covered in the Europe automated external defibrillator (AED) market report are U.K., Germany, France, Italy, Spain, Netherlands, Switzerland, Belgium, Sweden, Denmark, Norway, Finland, Austria, Ireland, and Rest of Europe
U.K. dominates the Europe automated external defibrillator (AED) market because of the strong base of healthcare facilities, strong presence of major players in the market, increases cases of cardiovascular disease among and rising number of geriatric population in this region.
The country section of the report also provides individual market impacting factors and changes in regulation in the market domestically that impacts the current and future trends of the market. Data points like down-stream and upstream value chain analysis, technical trends and porter's five forces analysis, case studies are some of the pointers used to forecast the market scenario for individual countries. Also, the presence and availability of Europe brands and their challenges faced due to large or scarce competition from local and domestic brands, impact of domestic tariffs and trade routes are considered while providing forecast analysis of the country data.
Healthcare Infrastructure Growth Installed base and New Technology Penetration
The Europe automated external defibrillator (AED) market also provides you with detailed market analysis for every country growth in healthcare expenditure for capital equipment, installed base of different kind of products for Europe automated external defibrillator (AED) market, impact of technology using life line curves and changes in healthcare regulatory scenarios and their impact on the Europe automated external defibrillator (AED) market. The data is available for historic period 2015-2020.
Competitive Landscape and Europe Automated External Defibrillator (AED) Market Share Analysis
The Europe automated external defibrillator (AED) market competitive landscape provides details by competitor. Details included are company overview, company financials, revenue generated, market potential, investment in research and development, new market initiatives, Europe presence, production sites and facilities, production capacities, company strengths and weaknesses, product launch, product width and breadth, application dominance. The above data points provided are only related to the companies' focus related to Europe automated external defibrillator (AED) market.
Some of the major players operating in the Europe automated external defibrillator (AED) market are:
- Philips Healthcare (Netherlands)
- GE Healthcare (U.S.)
- Siemens Healthineers (Germany)
- Hillrom Holdings, Inc. (U.S.)
- Schiller AG (Switzerland)
- Fukuda Denshi Co., Ltd. (Japan)
- Mindray Medical International Limited (China)
- Nihon Kohden Corporation (Japan)
- Mortara Instrument, Inc. (U.S.)
- BPL Medical Technologies (India)
- Medtronic plc (U.S.)
SKU-